Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment

NCT01823965 Phase 2 COMPLETED

In the prospective monocentric open label trial patients with diabetic macular edema will be treated with intravitreal injections of ranibizumab given for 3 months then with laser grid at month 4. During follow-up a ranibizumab injection will be performed every 2 months in case of best-corrected visual acuity decreased more than 5 letters.

Details

Lead sponsor	Poitiers University Hospital
Phase	Phase 2
Status	COMPLETED
Enrolment	35
Start date	2011-10
Completion	2014-07

Conditions

• Diabetic Macular Edema

Interventions

• ranibizumab

Primary outcomes

• Number of intravitreal injections of ranibizumab — 1 years

Countries

France